|
ImQuest Life Sciences has an interest in developing chemotherapeutic agents for the treatment of solid and hematopoietic tumors. ImQuest's interest is broad based but is focused on the identification of novel agents for the treatment of prostate, breast, colon and lung cancer, as well as leukemia and lymphomas. Our mission is to discover and develop agents with novel mechanism of action which will yield first in class drugs in the fight to eliminate the leading causes of death in the world. Although significant strides have been made in the fight against cancer, significant unmet medical needs still remain in our primary anti-cancer focus areas. ImQuest is working with our partners to identify novel methods of attacking tumor cells using both small molecule and immunomodulatory approaches. ImQuest is also directing research at viral-induced neoplasia caused by retroviruses such as HIV and HTLV, hepatitis B and C viruses, and other infectious organisms.
|
